Suppr超能文献

大鼠阿米洛利结合蛋白不同分子形式的分子克隆与功能表达

Molecular cloning and functional expression of different molecular forms of rat amiloride-binding proteins.

作者信息

Lingueglia E, Renard S, Voilley N, Waldmann R, Chassande O, Lazdunski M, Barbry P

机构信息

Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, Valbonne, France.

出版信息

Eur J Biochem. 1993 Sep 1;216(2):679-87. doi: 10.1111/j.1432-1033.1993.tb18188.x.

Abstract

The colon and lung amiloride-binding proteins were cloned from rat tissues. Two sizes of transcripts were identified. The 2.7-kb transcript codes for an 85-kDa protein, whereas the 1.2-kb transcript codes for a 25-kDa polypeptide. The 2.7-kb transcript was detected in the proximal and distal colon and in duodenum, liver, placenta and thymus. The 1.2-kb transcript was the only form present in lung and spleen, and it was also detected in placenta and colon. The short form corresponds to the 3' terminus of the longer one. It is formed by alternative transcription under the control of an internal promoter. Cells stably transfected with cDNAs encoding these two proteins were used for binding studies using [3H]phenamil, a potent blocker of the epithelial Na+ channel, derived from amiloride. Both the long and short forms of the protein bind amiloride and some of its derivatives, but they have distinct pharmacologies. The order of potency of the different amiloride derivatives to inhibit [3H]phenamil binding was phenamil (K0.5 = 10 nM) > benzamil (K0.5 = 43 nM) > amiloride (K0.5 = 1.4 microM) approximately ethylisopropylamiloride (K0.5 = 1.6 microM) for the long form, whereas it was phenamil (K0.5 = 68 nM) > amiloride (K0.5 = 3.2 microM) approximately ethylisopropylamiloride (K0.5 = 4 microM) approximately benzamil (K0.5 = 6.3 microM) for the short form. Although the binding proteins described here are distinct from the pore-forming protein of the epithelial Na+ channel, the pharmacological profile of the long form of the ABP is identical to that described previously in pig and human kidney, and similar to that expected for an epithelial Na+ channel. The pharmacological profile of the short form resembles that previously described for an amiloride-binding protein in pneumocytes. Results presented in this paper suggest that previously purified preparations showing Na+ channel activity contain different forms of the amiloride-binding protein, possibly associated with other proteins. The similarity between amiloride-binding proteins and a protein identified in seminal vesicles suggests that amiloride-binding proteins are the first members of a new family of epithelia-specific proteins.

摘要

从大鼠组织中克隆出结肠和肺阿米洛利结合蛋白。鉴定出两种大小的转录本。2.7kb的转录本编码一种85kDa的蛋白质,而1.2kb的转录本编码一种25kDa的多肽。在近端和远端结肠以及十二指肠、肝脏、胎盘和胸腺中检测到2.7kb的转录本。1.2kb的转录本是肺和脾中存在的唯一形式,在胎盘和结肠中也检测到。短形式对应于长形式的3'末端。它是由内部启动子控制下的选择性转录形成的。用编码这两种蛋白质的cDNA稳定转染的细胞用于使用[3H]苯那明进行结合研究,[3H]苯那明是一种源自阿米洛利的上皮钠通道强效阻滞剂。蛋白质的长形式和短形式都能结合阿米洛利及其一些衍生物,但它们具有不同的药理学特性。对于长形式,不同阿米洛利衍生物抑制[3H]苯那明结合的效力顺序为苯那明(K0.5 = 10 nM)>苄胺唑啉(K0.5 = 43 nM)>阿米洛利(K0.5 = 1.4 μM)≈乙基异丙基阿米洛利(K0.5 = 1.6 μM),而对于短形式,顺序为苯那明(K0.5 = 68 nM)>阿米洛利(K0.5 = 3.2 μM)≈乙基异丙基阿米洛利(K0.5 = 4 μM)≈苄胺唑啉(K0.5 = 6.3 μM)。尽管这里描述的结合蛋白与上皮钠通道的孔形成蛋白不同,但ABP长形式的药理学特征与先前在猪和人肾脏中描述的相同,并且与上皮钠通道预期的相似。短形式的药理学特征类似于先前在肺细胞中描述的阿米洛利结合蛋白的特征。本文给出的结果表明,先前纯化的显示钠通道活性的制剂含有不同形式的阿米洛利结合蛋白,可能与其他蛋白质相关。阿米洛利结合蛋白与在精囊中鉴定出的一种蛋白质之间的相似性表明,阿米洛利结合蛋白是上皮特异性蛋白新家族的首批成员。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验